114 related articles for article (PubMed ID: 22235430)
1. Neurospecific proteins in the serum of patients with brain tumors.
Lyubimova NV; Toms MG; Popova EE; Bondarenko YV; Krat VB; Kushlinskii NE
Bull Exp Biol Med; 2011 Apr; 150(6):732-4. PubMed ID: 22235430
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers of brain tumours.
Lyubimova NV; Toms MG; Fu RG; Bondarenko YV
Klin Lab Diagn; 2013 Oct; (10):71-2, 40-2. PubMed ID: 24640102
[TBL] [Abstract][Full Text] [Related]
3. Pathologic analysis of primary brain tumors.
McComb RD; Burger PC
Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
[TBL] [Abstract][Full Text] [Related]
4. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological study on malignant glioma--with special reference to GFAP].
Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
[TBL] [Abstract][Full Text] [Related]
6. Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial Tumors.
Lyubimova NV; Timofeev YS; Mitrofanov AA; Bekyashev AK; Goncharova ZA; Kushlinskii NE
Bull Exp Biol Med; 2020 Feb; 168(4):503-506. PubMed ID: 32147765
[TBL] [Abstract][Full Text] [Related]
7. [Significance of immunohistochemistry in neuro-oncology. I. Demonstration of glial fibrillary acid protein (GFAP) in extracranial metastases from primary brain tumors].
Gottschalk J; Martin H; Kretschmer B; Barz H; Janda J; Szymas J
Zentralbl Allg Pathol; 1985; 130(5):391-6. PubMed ID: 3913231
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.
Nduom EK; Yang C; Merrill MJ; Zhuang Z; Lonser RR
J Neurosurg; 2013 Aug; 119(2):427-33. PubMed ID: 23621605
[TBL] [Abstract][Full Text] [Related]
9. Expression of neuronal markers, NFP and GFAP, in malignant astrocytoma.
Hashemi F; Naderian M; Kadivar M; Nilipour Y; Gheytanchi E
Asian Pac J Cancer Prev; 2014; 15(15):6315-9. PubMed ID: 25124617
[TBL] [Abstract][Full Text] [Related]
10. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
11. Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases.
Duenisch P; Reichart R; Mueller U; Brodhun M; Bjerkvig R; Romeike B; Walter J; Herbold C; Regenbrecht CR; Kalff R; Kuhn SA
J Cancer Res Clin Oncol; 2011 Mar; 137(3):399-414. PubMed ID: 20440511
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors.
Hara A; Hirose Y; Yoshimi N; Tanaka T; Mori H
Neurol Res; 1997 Dec; 19(6):623-8. PubMed ID: 9427964
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of S-phase cells in human gliomas].
Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours.
Camby I; Lefranc F; Titeca G; Neuci S; Fastrez M; Dedecken L; Schäfer BW; Brotchi J; Heizmann CW; Pochet R; Salmon I; Kiss R; Decaestecker C
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):76-90. PubMed ID: 10736069
[TBL] [Abstract][Full Text] [Related]
16. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.
Higuchi M; Ohnishi T; Arita N; Hiraga S; Hayakawa T
Acta Neuropathol; 1993; 85(5):481-7. PubMed ID: 7684178
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
[TBL] [Abstract][Full Text] [Related]
18. [The glio-fibrillar acid protein in blood serum of patients with brain tumors and neurological diseases of non-tumorous etiology].
Lyubimova NV; Timofeiev YS; Sushlinskii NE
Klin Lab Diagn; 2016 Aug; 61(8):466-9. PubMed ID: 30601636
[TBL] [Abstract][Full Text] [Related]
19. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
[TBL] [Abstract][Full Text] [Related]
20. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
Kimura T; Budka H; Soler-Federsppiel S
Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
